Identification of peptides presented by HLA class I molecules on cervical cancer cells with HPV-18 infection (original) (raw)
Identification of two homologous antigenic peptides derived from L1 HPV16 and 18 proteins specific for the HLA-B*3901 allele
Claudia Hernández Montes
Archives of Virology, 2002
View PDFchevron_right
Identification of two homologous antigenic peptides derived from L1 HPV-16 and 18 proteins specific for the HLA-B*3901 allele
BENNY WEISS, Jorge Hernández-Montes, Alberto Monroy-garcia
Archives of Virology, 2002
View PDFchevron_right
Identification of a naturally processed HLA-A*0201 HPV18 E7 T cell epitope by tumor cell mediatedin vitro vaccination
Andreas Kaufmann
International Journal of Cancer, 2003
View PDFchevron_right
Identification of a naturally processed HLA A0201‐restricted viral peptide from cells expressing human papillomavirus type 16 E6 oncoprotein
Alfonso Ferrara
European Journal of Immunology, 1994
View PDFchevron_right
Papillomavirus-E7 Peptides Provided by Human Recognize HLA-DR-Restricted Lymphocytes in Cervical Cancer Tumor-Infiltrating + CD4
Markus Maeurer
2010
View PDFchevron_right
Human Papillomavirus Type 33 E7 Peptides Presented by HLA-DR*0402 to Tumor-Infiltrating T Cells in Cervical Cancer
Markus Maeurer
Journal of Virology, 2000
View PDFchevron_right
Natural T-helper immunity against human papillomavirus type 16 (hpv16) e7-derived peptide epitopes in patients with hpv16-positive cervical lesions: Identification of 3 human leukocyte antigen class ii-restricted epitopes
Tom h.m. Ottenhoff
International Journal of Cancer, 2001
View PDFchevron_right
Human T-cell responses to HLA-A-restricted high binding affinity peptides of human papillomavirus type 18 proteins E6 and E7
Cornelis Melief
Clinical cancer research : an official journal of the American Association for Cancer Research, 2001
View PDFchevron_right
Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells
Daphne Jansen, Mariet Feltkamp, Martin Kast
European Journal of Immunology, 1993
View PDFchevron_right
Differential binding of viral peptides to HLA-A2 alleles. Implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinoma
Remco Brandt, Martin Kast
European Journal of Immunology, 1999
View PDFchevron_right
A Conserved E7-derived Cytotoxic T Lymphocyte Epitope Expressed on Human Papillomavirus 16-transformed HLA-A2+ Epithelial Cancers
Karen Anderson
Journal of Biological Chemistry, 2010
View PDFchevron_right
Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I–II trial
Gert Fleuren
European Journal of Cancer, 1999
View PDFchevron_right
A Comprehensive in Silico Analysis for Identification of Immunotherapeutic Epitopes of HPV-18
Parikipandla sridevi
International Journal of Peptide Research and Therapeutics
View PDFchevron_right
Direct identification of an HPV-16 tumor antigen from cervical cancer biopsy specimens
Sun Lee, Derin Keskin
Frontiers in immunology, 2011
View PDFchevron_right
Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate HPV type 16-induced tumors
W. Martin Kast
2013
View PDFchevron_right
Design of a Synthetic Long Peptide Vaccine Targeting HPV-16 and -18 Using Immunoinformatic Methods
Corina VERNIC
Pharmaceutics
View PDFchevron_right
Cytotoxic T-Lymphocyte Responses to Human Papillomavirus Type 16 E5 and E7 Proteins and HLA-A*0201-Restricted T-Cell Peptides in Cervical Cancer Patients
岱瑋 劉
Journal of Virology, 2007
View PDFchevron_right
A synthetic chimeric peptide harboring human papillomavirus 16 cytotoxic T lymphocyte epitopes shows therapeutic potential in a murine model of cervical cancer
Chandresh Sharma
Immunologic Research, 2013
View PDFchevron_right
Purification and HPLC-MS analysis of a naturally processed HCMV-derived peptide isolated from the HEK-293T/HLA-E+/Ul40+ cell transfectants and presented at the cell surface in the context of HLA-E
Gabriella Pietra, Enrico Millo
Journal of Immunological Methods, 2007
View PDFchevron_right
Identification of promiscuous HPV16-derived T helper cell epitopes for therapeutic HPV vaccine design
Andreas Kaufmann
International Journal of Cancer, 2014
View PDFchevron_right
HLA-A2-restricted peripheral blood cytolytic T lymphocyte response to HPV type 16 proteins E6 and E7 from patients with neoplastic cervical lesions
Klaus Heeg
Cancer Immunology, Immunotherapy, 1996
View PDFchevron_right
HPV16 L1E7 chimeric virus-like particles induce specific HLA-restricted T cells in humans afterin vitro vaccination
Andreas Kaufmann
International Journal of Cancer, 2001
View PDFchevron_right
Immunization of mice by a multimeric L2-based linear epitope (17-36) from HPV type 16/18 induced cross reactive neutralizing antibodies
Arash Arashkia
View PDFchevron_right
Use of Fluorogenic Histocompatibility Leukocyte Antigen-A*0201/HPV 16 E7 Peptide Complexes to Isolate Rare Human Cytotoxic T-Lymphocyte- recognizing Endogenous Human Papillomavirus Antigens1
Alison Fiander
2000
View PDFchevron_right